MARK2 and Hypertension: Consistent with previously reported association of single nucleotide polymorphisms (SNPs) in the serine-threonine kinase STK33 gene with hypertension in Europeans (37), our investigation revealed several STK33 inhibitors as effective drugs targeting the attenuated LPS response associated with hypertension (Figure 4B).